Morgan Stanley Maintains Equal-Weight on GRAIL, Raises Price Target to $120
Morgan Stanley analyst Tejas Savant maintains GRAIL (NASDAQ:GRAL) with a Equal-Weight and raises the price target from $60 to $120.
Stocks · News reference
UBS Maintains Buy on GRAIL, Raises Price Target to $175
UBS analyst Doug Schenkel maintains GRAIL (NASDAQ:GRAL) with a Buy and raises the price target from $105 to $175.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
TD Cowen Maintains Buy on GRAIL, Raises Price Target to $180
TD Cowen analyst Dan Brennan maintains GRAIL (NASDAQ:GRAL) with a Buy and raises the price target from $88 to $180.
GRAIL To Present New NHS-Galleri Trial Data At Early Detection Of Cancer Conference And ESMO Congress